Chemotherapy is the standard internal medical treatment for cancer. However, the
resistance of cancer cells to nearly all kinds of chemotherapeutic drugs and targeted drugs …

Background Emerging studies indicate that hypericin has diverse pharmacological actions
and exhibits potential for treatment of various types of cancer. Purpose The current review …

Drug delivery systems have become an integral part of anticancer drugs today. Design of
novel drug carriers may lead to significant enhancement in antineoplastic therapy …

Objective Multidrug resistance (MDR) is the major barrier to the successful treatment of
chemotherapy. Compounds from nature products working as MDR sensitizers provided new …

We have previously reported that curcumin inhibits urothelial tumor development in a rat
bladder carcinogenesis model. In this study, we report that curcumin inhibits urothelial tumor …

The chemical investigation of marine mollusks has led to the isolation of a wide variety of
bioactive metabolites, which evolved in marine organisms as favorable adaptations to …

Overcoming multidrug resistance (MDR) is one of the major challenges in cancer therapy. In
this respect, Schiff base-related compounds (bearing a R 1 R 2 Cdouble bondNR 3 bond) …

The flavonolignan silibinin, the major bioactive component of the silymarin extract of Silybum
marianum (milk thistle) seeds, is gaining traction as a novel anti-cancer therapeutic. Here …

Background: Essential oils are complex mixtures of low molecular weight compounds
extracted from plants. Their main constituents are terpenes and phenylpropanoids, which …

Background Shikonin (SKN), a naphthoquinone compound, is isolated from Chinese herbal
medicine Lithospermum root and has been studied as an anticancer drug candidate in …